Ukraine has officially registered its first medical cannabis product, with oral cannabis drops developed in Spain expected to be available in pharmacies early this year. The announcement was made by Deputy Prime Minister for European and Euro-Atlantic Integration Olha Stefanyshyna and the Patients of Ukraine Charitable Foundation on Wednesday. This development comes a year after […]
Researchers in Toronto are delving deeper into how cannabis enhances users’ musical experiences with a new study set to run through early 2025. Building on their 2023 findings that marijuana boosts enjoyment of music, the team has partnered with Club Lit, a downtown cannabis consumption lounge, to survey consumers in a real-world setting. The goal
Health officials in France have announced an extension of the country’s experimental medical cannabis program until July 31, 2025. Originally set to expire on December 31, 2024, the program, which began in March 2021, has been extended in order to further study the effects of medical cannabis on patients suffering from chronic diseases. The initial
France Extends Medical Cannabis Program Until July 2025 Read More »
The Rutgers Institute for Health, Health Care Policy, and Aging Research has been awarded a $686,376 grant from the National Institute on Drug Abuse (NIDA) to explore the therapeutic benefits of medical use and investigate potential side effects and health risks. Led by Tammy Chung, a psychiatry professor at Rutgers Health, the research aims to
Rutgers Researchers Receive $686K Grant to Study Medical Benefits and Risks Read More »
In a significant move for medical cannabis research, the U.S. Food and Drug Administration (FDA) has approved a clinical trial to explore the potential benefits of smoking or vaping cannabis products to treat post-traumatic stress disorder (PTSD) among veterans. The study, which aims to provide vital insights into how cannabis can help manage PTSD symptoms,
FDA Approves Clinical Trial to Investigate Cannabis for PTSD in Veterans Read More »
Kentucky is taking a significant step toward launching its medical program as patient certifications open on December 1, according to WLKY. During last week’s Team Kentucky update, Gov. Andy Beshear confirmed the launch of a webpage at kymedcan.ky.gov to connect patients with over 150 authorized healthcare providers. Certified patients can begin applying for medical ID
Kentucky to Begin Medical Program Patient Certifications December 1 Read More »
The U.S. Department of Agriculture (USDA) has announced a one-year delay in enforcing a rule requiring hemp products sold in the United States to be tested by labs registered with the Drug Enforcement Administration (DEA). This marks the third consecutive year the USDA has postponed the enforcement of the regulation, which was initially set to
USDA Delays Enforcement of Hemp Testing Rule for Third Year Read More »
The Massachusetts Cannabis Control Commission (CCC) has issued new health and safety guidelines for the cannabis industry, designating “ground cannabis dust” as a hazardous material. This new regulation comes nearly three years after the tragic death of 27-year-old Lorna McMurrey, a cannabis worker who died from an asthma attack while working at a Trulieve cannabis
Massachusetts voters rejected a groundbreaking measure that sought to legalize medicinal psychedelics, including psilocybin, DMT, and mescaline, for therapeutic use. The measure, which was defeated by a 57% to 43% margin, would have paved the way for the legal use of psychedelics in treating mental health conditions like depression, anxiety, PTSD, and substance use disorders.
Massachusetts Voters Reject Measure to Legalize Medicinal Psychedelics Read More »
A recent Gallup poll reveals that 15% of Americans report currently smoking cannabis, a steady increase from the 14% average recorded between 2021 and 2022. Released on November 1, 2024, this data reflects a gradual rise in cannabis use across the U.S., although overall support for legalization saw a slight dip, moving from 70% last
